InspireMD Inc. short interest in 2019
In 2019, InspireMD Inc.'s disclosed short interest ran from 3.91% of shares outstanding on 15 Jan 2019 to 2.90% on 31 Dec 2019, a change of -1.01 percentage points. The year's high was 13.50% on 31 May 2019 and its low 1.56% on 29 Mar 2019, averaging 6.35% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.83 days on 15 Jul 2019. Full history: InspireMD Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 3.91% (15 Jan 2019)
- End of year
- 2.90% (31 Dec 2019)
- Change
- -1.01 pp
- High
- 13.50% (31 May 2019)
- Low
- 1.56% (29 Mar 2019)
- Average
- 6.35%
- Highest days to cover
- 11.83 (15 Jul 2019)
- SEC filings marked
- 10
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 3.91% | 1.86 | results (8-K) |
| 31 Jan 2019 | 3.81% | 1.00 | |
| 15 Feb 2019 | 2.69% | 1.00 | |
| 28 Feb 2019 | 1.60% | 1.00 | 10-K filed, results (8-K) |
| 15 Mar 2019 | 1.80% | 1.00 | |
| 29 Mar 2019 | 1.56% | 1.00 | results (8-K) |
| 15 May 2019 | 8.98% | 1.00 | 10-Q filed, results (8-K) |
| 31 May 2019 | 13.50% | 2.35 | |
| 14 Jun 2019 | 10.50% | 3.80 | |
| 28 Jun 2019 | 9.19% | 4.76 | |
| 15 Jul 2019 | 8.64% | 11.83 | |
| 31 Jul 2019 | 8.00% | 9.76 | |
| 15 Aug 2019 | 7.43% | 2.76 | 10-Q filed, results (8-K) |
| 30 Aug 2019 | 9.51% | 1.00 | |
| 13 Sep 2019 | 10.87% | 1.00 | |
| 30 Sep 2019 | 6.91% | 1.00 | |
| 15 Oct 2019 | 6.47% | 1.00 | |
| 31 Oct 2019 | 8.72% | 1.31 | |
| 15 Nov 2019 | 3.08% | 1.00 | 10-Q filed, results (8-K) |
| 13 Dec 2019 | 3.20% | 1.32 | |
| 31 Dec 2019 | 2.90% | 1.10 |
See also: InspireMD Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.